Total assets · 2011–2025
Neurocrine Biosciences total assets
$4.6B+24.5% · FY2025
Neurocrine Biosciences (NBIX) reported $4.6B in total assets for fiscal 2025, +24.5% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $4.6B | +24.5% | Open → |
| FY20242024-12-31 | $3.7B | +14.4% | Open → |
| FY20232023-12-31 | $3.3B | +37.3% | Open → |
| FY20222022-12-31 | $2.4B | +14.3% | Open → |
| FY20212021-12-31 | $2.1B | +19.5% | Open → |
| FY20202020-12-31 | $1.7B | +32.8% | Open → |
| FY20192019-12-31 | $1.3B | +31.5% | Open → |
| FY20182018-12-31 | $993M | +21.5% | Open → |
| FY20172017-12-31 | $818M | +123.9% | Open → |
| FY20162016-12-31 | $365M | −23.1% | Open → |
| FY20152015-12-31 | $475M | +95.4% | Open → |
| FY20142014-12-31 | $243M | +57.1% | Open → |
| FY20132013-12-31 | $155M | −21.1% | Open → |
| FY20122012-12-31 | $196M | +41.6% | Open → |
| FY20112011-12-31 | $138M | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +28.5%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Neurocrine Biosciences total assets |url=https://companiesranked.com/en/company/neurocrine-biosciences/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Neurocrine Biosciences total assets. CompaniesRanked. https://companiesranked.com/en/company/neurocrine-biosciences/total-assetsBibTeX
@misc{companiesranked-en-company-neurocrine-biosciences-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Neurocrine Biosciences total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/neurocrine-biosciences/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000914475-26-000037 · July 31, 2026
{{cite web |title=Neurocrine Biosciences total assets — 10-Q (0000914475-26-000037) |url=https://www.sec.gov/Archives/edgar/data/914475/000091447526000037/nbix-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-31}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.